Literature DB >> 18456418

Running, esophageal acid reflux, and atrial fibrillation: a chain of events linked by evidence from separate medical literatures.

Don R Swanson1.   

Abstract

Using a previously described approach to generating novel medical hypotheses, this paper shows how two separate medical literatures taken together can suggest new information not apparent in either literature alone. Many studies have demonstrated that aerobic exercise in healthy people can induce esophageal acidic reflux that increases with the duration and intensity of exercise. Separately, independently of exercise, it has been shown that, in patients with gastroesophageal reflux, esophageal acid exposure can lead to atrial fibrillation (AF) and to other heart dysrhythmias. The two arguments together suggest that a regimen of excessive exercise may be conducive to AF mediated by acid reflux, an implicit, but unpublished, hypothesis. Proton pump inhibitors are widely used to treat gastroesophageal reflux. Remarkably, several small clinical trials of these drugs have been shown also to reduce symptoms and frequency of AF episodes in patients with comorbid acid reflux. Plausible mechanisms have been suggested. These small-scale tests in a highly restricted population may be of particular interest in the light of a possible exercise-reflux-AF causal chain of events in a broader population of athletes. Because the minimum degree of esophageal acidity exposure required to induce AF is unknown, further tests of proton pump inhibitors for that purpose are therefore merited without regard to any known prior reflux in a population of runners with lone AF. The prospect of reducing AF burden with a relatively benign agent is attractive in view of the limited options for effective treatment otherwise available. The study of arrhythmia and esophageal reflux in athletes may offer insights on the origin and natural history of lone atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456418      PMCID: PMC3690799          DOI: 10.1016/j.mehy.2008.02.017

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  32 in total

Review 1.  Gastroesophageal reflux in athletes.

Authors:  Katrina Parmelee-Peters; James L Moeller
Journal:  Curr Sports Med Rep       Date:  2004-04       Impact factor: 1.733

2.  The effect of different types of exercise on gastro-oesophageal reflux.

Authors:  E Yazaki; A Shawdon; I Beasley; D F Evans
Journal:  Aust J Sci Med Sport       Date:  1996-12

3.  Effect of graded exercise on esophageal motility and gastroesophageal reflux in trained athletes.

Authors:  E E Soffer; R K Merchant; G Duethman; J Launspach; C Gisolfi; T E Adrian
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

4.  Effect of graded exercise on esophageal motility and gastroesophageal reflux in nontrained subjects.

Authors:  E E Soffer; J Wilson; G Duethman; J Launspach; T E Adrian
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

5.  Gastroesophageal reflux in runners. Characteristics and treatment.

Authors:  B B Kraus; J W Sinclair; D O Castell
Journal:  Ann Intern Med       Date:  1990-03-15       Impact factor: 25.391

6.  The effect of omeprazole on gastro-oesophageal reflux and symptoms during strenuous exercise.

Authors:  H P Peters; A F De Kort; H Van Krevelen; L M Akkermans; G P Van Berge Henegouwen; E Bol; W L Mosterd; W R De Vries
Journal:  Aliment Pharmacol Ther       Date:  1999-08       Impact factor: 8.171

7.  Atrial arrhythmia burden as an endpoint in clinical trials: is it the best surrogate? Lessons from a multicenter defibrillator trial.

Authors:  David E Euler; Paul A Friedman
Journal:  Card Electrophysiol Rev       Date:  2003-12

8.  Esophagogastric junction morphology predicts susceptibility to exercise-induced reflux.

Authors:  John E Pandolfino; Laura K Bianchi; Thomas J Lee; Ikuo Hirano; Peter J Kahrilas
Journal:  Am J Gastroenterol       Date:  2004-08       Impact factor: 10.864

9.  Paroxysmal atrial fibrillation: a disorder of autonomic tone?

Authors:  P Coumel
Journal:  Eur Heart J       Date:  1994-04       Impact factor: 29.983

10.  Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease.

Authors:  David A Johnson; M Brian Fennerty
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

View more
  7 in total

Review 1.  Atrial fibrillation and long-term sports practice: epidemiology and mechanisms.

Authors:  S Wernhart; M Halle
Journal:  Clin Res Cardiol       Date:  2014-12-25       Impact factor: 5.460

2.  Chronic exercise: a contributing factor to atrial fibrillation?

Authors:  Xander H T Wehrens; David Y Chiang; Na Li
Journal:  J Am Coll Cardiol       Date:  2013-04-09       Impact factor: 24.094

Review 3.  Atrial Fibrillation in Athletes: The Role of Exercise.

Authors:  Mohit K Turagam Md; Poonam Velagapudi Md; Abraham G Kocheril Md
Journal:  J Atr Fibrillation       Date:  2014-02-28

Review 4.  Atrial Fibrillation In Athletes: Pathophysiology, Clinical Presentation, Evaluation and Management.

Authors:  Mohit K Turagam; Greg C Flaker; Poonam Velagapudi; Sirisha Vadali; Martin A Alpert
Journal:  J Atr Fibrillation       Date:  2015-12-31

Review 5.  Atrial fibrillation in patients with gastroesophageal reflux disease: a comprehensive review.

Authors:  Crina Roman; Stanislas Bruley des Varannes; Lucian Muresan; Alina Picos; Dan L Dumitrascu
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

6.  Assessment of the p wave dispersion and duration in elite women basketball players.

Authors:  Gokhan Metin; Mustafa Yildiz; Bulent Bayraktar; Ilker Yucesir; Hasan Kasap; Lutfi Cakar
Journal:  Indian Pacing Electrophysiol J       Date:  2010-01-07

Review 7.  Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter.

Authors:  Lluís Mont; Roberto Elosua; Josep Brugada
Journal:  Europace       Date:  2008-11-06       Impact factor: 5.214

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.